drugset / Trial / NCT06092684
The Efficacy and Safety of Esketamine in Elective Laparoscopic Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective is to evaluate the efficacy and safety of BT-KTM-I(Esketamine Hydrochloride Injection produced by Chengdu Brilliant Pharmaceutical Co., Ltd.) for general anesthesia, using the Originator drug Ketanest®S(Esketamine Hydrochloride Injection) as a positive control.
Timeline
- Start
- 2023-09-20
- Primary completion
- 2024-03-19
- Completion
- 2024-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.5 mg/kg | — |
Indications
No indication recorded.